Remyelination In Multiple Sclerosis

International Review of Neurobiology

Volumn 79, Issue , 2007, Pages 589-620

  Chari, Divya M ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BIOLOGICAL MODEL; DISEASE MODEL; HUMAN; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE REGENERATION; OLIGODENDROGLIA; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MODELS, BIOLOGICAL; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE REGENERATION; OLIGODENDROGLIA;

EID: 34248657276     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(07)79026-8     Document Type: Review

References (147)

1. Adams C.W.M. "A Colour Atlas of Multiple Sclerosis and Other Myelin Disorders." (1989), Wolfe Medical Publications, London
2. Antony J.M., van Marle G., Opii W., Butterfield D.A., Mallet F., Yong V.W., Wallace J.L., Deacon R.M., Warren K., and Power C. Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat. Neurosci. 7 (2004) 1088-1095
3. Arnett H.A., Mason J., Marino M., Suzuki K., Matsushima G.K., and Ting J.P. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat. Neurosci. 4 (2001) 1116-1122
4. Arnett H.A., Wang Y., Matsushima G.K., Suzuki K., and Ting J.P. Functional genomic analysis of remyelination reveals importance of inflammation in oligodendrocyte regeneration. J. Neurosci. 23 (2003) 9824-9832
5. Arnett H.A., Fancy S.P., Alberta J.A., Zhao C., Plant S.R., Kaing S., Raine C.S., Rowitch D.H., Franklin R.J., and Stiles C.D. bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science 17 (2004) 2111-2115
6. Ayers M.M., Hazelwood L.J., Catmull D.V., Wang D., McKormack Q., Bernard C.C., and Orian J.M. Early glial responses in murine models of multiple sclerosis. Neurochem. Int. 45 (2004) 409-419
7. Back S.A., Tuohy T.M., Chen H., Wallingford N., Craig A., Struve J., Luo N.L., Banine F., Liu Y., Chang A., Trapp B.D., Bebo B.F., et al. Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat. Med. 11 (2005) 966-972
8. Barnett M.H., and Prineas J.W. Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion. Ann. Neurol. 55 (2004) 458-468
9. Barnett S.C., and Riddell J.S. Olfactory ensheathing cells (OECs) and the treatment of CNS injury: Advantages and possible caveats. J. Anat. 204 (2004) 57-67 Review
10. Bergles D.E., Bergles D.E., Roberts J.D., Somogyi P., and Jahr C.E. Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus. Nature 405 (2000) 187-191
11. Bieber A.J., Kerr S., and Rodriguez M. Efficient central nervous system remyelination requires T cells. Ann. Neurol. 53 (2003) 680-684
12. Black J.A., Waxman S.G., and Smith K.J. Remyelination of dorsal column axons by endogenous Schwann cells restores the normal pattern of Nav1. 6 and Kv1. 2 at nodes of Ranvier. Brain 129 (2006) 1319-1329
13. Blakemore W.F. The case for a central nervous system (CNS) origin for the Schwann cells that remyelinate CNS axons following concurrent loss of oligodendrocytes and astrocytes. Neuropathol. Appl. Neurobiol. 31 (2005) 1-10
14. Blakemore W.F., and Patterson R.C. Suppression of remyelination in the CNS by X-irradiation. Acta Neuropathol. Berl. 42 (1978) 105-113
15. Blakemore W.F., Chari D.M., Gilson J.M., and Crang A.J. Modelling large areas of demyelination in the rat reveals the potential and possible limitations of transplanted glial cells for remyelination in the CNS. Glia 15 (2002) 155-168
16. Blakemore W.F., Gilson J.M., and Crang A.J. The presence of astrocytes in areas of demyelination influences remyelination following transplantation of oligodendrocyte progenitors. Exp. Neurol. 184 (2003) 955-963
17. Brockschnieder D., Lappe-Siefke C., Goebbels S., Boesl M.R., Nave K.A., and Riethmacher D. Cell depletion due to diphtheria toxin fragment A after Cre-mediated recombination. Mol. Cell. Biol. 24 (2004) 7636-7642
18. Buch T., Heppner F.L., Tertilt C., Heinen T.J., Kremer M., Wunderlich F.T., Jung S., and Waisman A. A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat. Methods 2 (2005) 419-426
19. Bunge M.B., Bunge R.P., and Ris H. Ultrastructural study of remyelination in an experimental lesion in adult cat spinal cord. J. Biophys. Biochem. Cytol. 10 (1961) 67-94
20. Bunge R.P. Regenerative phenomena in the feline spinal cord in late stages of lesions inflicted by cerebrospinal fluid manipulation. Anat. Rec. 130 (1958) 279
21. Bunge R.P., and Settlage P.H. Neurological lesions in cats following cerebrospinal fluid manipulation. J. Neuropathol. Exp. Neurol. 16 (1957) 471-491
22. Butt A.M., Duncan A., Hornby M.F., Kirvell S.L., Hunter A., Levine J.M., and Berry M. Cells expressing the NG2 antigen contact nodes of Ranvier in adult CNS white matter. Glia 26 (1999) 84-91
23. Byravan S., Foster L.M., Phan T., Verity A.N., and Campagnoni A.T. Murine oligodendroglial cells express nerve growth factor. Proc. Natl. Acad. Sci. USA 91 (1994) 8812-8816
24. Cajal S.R. "Degeneration and Regeneration of the Central Nervous System," (1928), Humphrey Milford/Oxford University Press, London 734-760
25. Carson M.J., Behringer R.R., Brinster R.L., and McMorris F.A. Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron 10 (1993) 729-740
26. Chang A., Nishiyama A., Peterson J., Prineas J., and Trapp B.D. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J. Neurosci. 20 (2000) 6404-6412
27. Chang A., Tourtellotte W.W., Rudick R., and Trapp B.D. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N. Engl. J. Med. 346 (2002) 165-173
28. Chari D.M., and Blakemore W.F. Efficient recolonisation of progenitor-depleted areas of the CNS by adult oligodendrocyte progenitor cells. Glia 37 (2002) 307-313
29. Chari D.M., and Blakemore W.F. New insights into remyelination failure in multiple sclerosis: Implications for glial cell transplantation. Mult. Scler. 8 (2002) 271-277 Review
30. Chari D.M., Crang A.J., and Blakemore W.F. Decline in rate of colonization of oligodendrocyte progenitor cell (OPC)-depleted tissue by adult OPCs with age. J. Neuropathol. Exp. Neurol. 62 (2003) 908-916
31. Chari D.M., Huang W.L., and Blakemore W.F. Dysfunctional oligodendrocyte progenitor cell (OPC) populations may inhibit repopulation of OPC depleted tissue. J. Neurosci. Res. 73 (2003) 787-793
32. Chari D.M., Zhao C., Kotter M.R., Blakemore W.F., and Franklin R.J. Corticosteroids delay remyelination of experimental demyelination in the rodent central nervous system. J. Neurosci. Res. 83 (2006) 594-605
33. Chari D.M., Gilson J.M., Franklin R.J., and Blakemore W.F. Oligodendrocyte progenitor cell (OPC) transplantation is unlikely to offer a means of preventing X-irradiation induced damage in the CNS. Exp. Neurol. 198 (2006) 145-153
34. Christensen T. Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses. Rev. Med. Virol. 15 (2005) 179-211 Review
35. Coman I., Barbin G., Charles P., Zalc B., and Lubetzki C. Axonal signals in central nervous system myelination, demyelination and remyelination. J. Neurol. Sci. 233 (2005) 67-71 Review
36. Crang A.J., Gilson J.M., Li W.W., and Blakemore W.F. The remyelinating potential and in vitro differentiation of MOG-expressing oligodendrocyte precursors isolated from the adult rat CNS. Eur. J. Neurosci. 20 (2004) 1445-1460
37. Crockett D.P., Burshteyn M., Garcia C., Muggironi M., and Casaccia-Bonnefil P. Number of oligodendrocyte progenitors recruited to the lesioned spinal cord is modulated by the levels of the cell cycle regulatory protein p27Kip-1. Glia 49 (2005) 301-308
38. Demerens C., Stankoff B., Logak M., Anglade P., Allinquant B., Couraud F., Zalc B., and Lubetzki C. Induction of myelination in the central nervous system by electrical activity. Proc. Natl. Acad. Sci. USA 93 (1996) 9887-9892
39. Dubois-Dalcq M., Ffrench-Constant C., and Franklin R.J. Enhancing central nervous system remyelination in multiple sclerosis. Neuron 48 (2005) 9-12 Review
40. Dugandzija-Novakovic S., Koszowski A.G., Levinson S.R., and Shrager P. Clustering of Na+ channels and node of Ranvier formation in remyelinating axons. J. Neurosci. 15 (1995) 492-503
41. Duncan I.D. Remyelination and restoration of axonal function by glial cell transplantation. Ernst Schering Res. Found. Workshop 53 (2005) 115-132 Review
42. Durand B., and Raff M. A cell-intrinsic timer that operates during oligodendrocyte development. Bioessays 22 (2000) 64-71 Review
43. Edgar J.M., McLaughlin M., Yool D., Zhang S.C., Fowler J.H., Montague P., Barrie J.A., McCulloch M.C., Duncan I.D., Garbern J., Nave K.A., and Griffiths I.R. Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J. Cell Biol. 166 (2004) 121-131
44. Ercolini A.M., and Miller S.D. Mechanisms of immunopathology in murine models of central nervous system demyelinating disease. J. Immunol. 176 (2006) 3293-3298 Review
45. Fancy S.P., Zhao C., and Franklin R.J. Increased expression of Nkx2. 2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS. Mol. Cell. Neurosci. 27 (2004) 247-254
46. Ferguson B., Matyszak M.K., Esiri M.M., and Perry V.H. Axonal damage in multiple sclerosis lesions. Brain 120 (1997) 393-399
47. Foote A.K., and Blakemore W.F. Inflammation stimulates remyelination in areas of chronic demyelination. Brain 128 (2005) 528-539
48. Franklin R.J. Why does remyelination fail in multiple sclerosis?. Nat. Rev. Neurosci. 3 (2002) 705-714 Review
49. Franklin R.J., and Hinks G.L. Understanding CNS remyelination: Clues from developmental and regeneration biology. J. Neurosci. Res 58 (1999) 207-213 Review
50. Franklin R.J., Bayley S.A., and Blakemore W.F. Transplanted CG4 cells (an oligodendrocyte progenitor cell line) survive, migrate, and contribute to repair of areas of demyelination in X-irradiated and damaged spinal cord but not in normal spinal cord. Exp. Neurol. 137 (1996) 263-276
51. Franklin R.J.M., and Blakemore W.F. Requirements for Schwann cell migration within CNS environments: A viewpoint. Int. J. Dev. Neurosci. 11 (1993) 641-649
52. Franklin R.J.M., Crang A.J., and Blakemore W.F. Transplanted type-1 astrocytes facilitate repair of demyelinating lesions by host oligodendrocytes in adult rat spinal cord. J. Neurocytol. 20 (1991) 420-430
53. Frost E.E., Nielsen J.A., Le T.Q., and Armstrong R.C. PDGF and FGF2 regulate oligodendrocyte progenitor responses to demyelination. J. Neurobiol. 54 (2003) 457-472
54. Fruttiger M., Karlsson L., Hall A.C., Abramsson A., Calver A.R., Bostrom H., Willetts K., Bertold C.H., Heath J.K., Betsholtz C., and Richardson W.D. Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice. Development 126 (1999) 457-467
55. Gallo V., Ghiani C.A., and Yuan X. The role of ion channels and neurotransmitter receptors in glial cell development. In: Jessen K.R., and Richardson W.D. (Eds). "Glial Cell Development" (2001), Oxford University Press, New York 109-130
56. Garbern J.Y., Yool D.A., Moore G.J., Wilds I.B., Faulk M.W., Klugmann M., Nave K.A., Sistermans E.A., van der Knaap M.S., Bird T.D., Shy M.E., Kamholz J.A., et al. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 125 (2002) 551-561
57. Ghatak N.R., Leshner R.T., Price A.C., and Felton W.L. Remyelination in the human central nervous system. J. Neuropathol. Exp. Neurol. 48 (1989) 507-518
58. Gilson J., and Blakemore W.F. Failure of remyelination in areas of demyelination produced in the spinal cord of old rats. Neuropathol. Appl. Neurobiol. 19 (1993) 173-181
59. Graca D.L., and Blakemore W.F. Delayed remyelination in the rat spinal cord following ethidium bromide injection. Neuropathol. Appl. Neurobiol. 12 (1986) 593-605
60. Griffiths I.R., Klugmann M., Anderson T., Yool D., Thomson C., Schwab M.H., Schneider A., Zimmermann F., McCulloch M., Nadon N., and Nave K.A. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280 (1998) 1610-1613
61. Groves A.K., Barnett S.C., Franklin R.J., Crang A.J., Mayer M., Blakemore W.F., and Noble M. Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells. Nature 362 (1993) 453-455
62. Gveric D., Cuzner M.L., and Newcombe J. Insulin-like growth factors and binding proteins in multiple sclerosis plaques. Neuropathol. Appl. Neurobiol. 25 (1999) 215-225
63. Hemmer B., Archelos J.J., and Hartung H.P. New concepts in the immunopathogenesis of multiple sclerosis. Nat. Rev. Neurosci. 3 (2002) 291-301 Review
64. Hinks G.L., and Franklin R.J.M. Distinctive patterns of PDGF-A, FGF-2, IGF-I, and TGF-beta1 gene expression during remyelination of experimentally-induced spinal cord demyelination. Mol. Cell. Neurosci. 14 (1999) 153-168
65. Ibrahim A., Li Y., Li D., Raisman G., and El Masry W.S. Olfactory ensheathing cells: Ripples of an incoming tide?. Lancet Neurol. 5 (2006) 453-457 Review
66. Itoyama Y., Webster H.D., Richardson E.P., and Trapp B.D. Schwann cell remyelination of demyelinated axons in spinal cord multiple sclerosis lesions. Ann. Neurol. 14 (1983) 339-346
67. Itoyama Y., Ohnishi A., Tateishi J., Kuroiwa Y., and Webster H.D. Spinal cord multiple sclerosis lesions in Japanese patients: Schwann cell remyelination occurs in areas that lack glial fibrillary acidic protein (GFAP). Acta Neuropathol. (Berl.) 65 (1985) 217-223
68. Jeffery N.D., and Blakemore W.F. Locomotor deficits induced by experimental spinal cord demyelination are abolished by spontaneous remyelination. Brain 120 (1997) 27-37
69. John G.R., Shankar S.L., Shafit-Zagardo B., Massimi A., Lee S.C., Raine C.S., and Brosnan C.F. Multiple sclerosis: Re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat. Med. 8 (2002) 1115-1121
70. Jones S.J. Visual evoked potentials after optic neuritis. Effect of time interval, age and disease dissemination. J. Neurol. 240 (1993) 489-494
71. Jurynczyk M., Jurewicz A., Bielecki B., Raine C.S., and Selmaj K. Inhibition of Notch signaling enhances tissue repair in an animal model of multiple sclerosis. J. Neuroimmunol. 170 (2005) 3-10
72. Keirstead H.S. Stem cells for the treatment of myelin loss. Trends Neurosci. 28 (2005) 677-683
73. Keirstead H.S., and Blakemore W.F. Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord. J. Neuropathol. Exp. Neurol. 56 (1997) 1191-1201
74. Keirstead H.S., Levine J.M., and Blakemore W.F. Response of the oligodendrocyte progenitor cell population (defined by NG2 labelling) to demyelination of the adult spinal cord. Glia 22 (1998) 161-170
75. Kerschensteiner M., Stadelmann C., Buddeberg B.S., Merkler D., Bareyre F.M., Anthony D.C., Linington C., Bruck W., and Schwab M.E. Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis. Am. J. Pathol. 164 (2004) 1455-1469
76. Kornek B., Storch M.K., Weissert R., Wallstroem E., Stefferl A., Olsson T., Linington C., Schmidbauer M., and Lassmann H. Multiple sclerosis and chronic autoimmune encephalomyelitis: A comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am. J. Pathol. 157 (2000) 267-276
77. Kotter M.R., Setzu A., Sim F.J., Van Rooijen N., and Franklin R.J.M. Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination. Glia 35 (2001) 204-212
78. Kotter M.R., Zhao C., van Rooijen N., and Franklin R.J. Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiol. Dis. 18 (2005) 166-175
79. Lappe-Siefke C., Goebbels S., Gravel M., Nicksch E., Lee J., Braun P.E., Griffiths I.R., and Nave K.A. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat. Genet. 33 (2003) 366-374
80. Lassmann H. "Comparative Neuropathology of Chronic Experimental Allergic Encephalomyelitis and Multiple Sclerosis." (1983), Springer, Berlin
81. Lassmann H., Bruck W., Lucchinetti C., and Rodriguez M. Remyelination in multiple sclerosis. Mult. Scler. 3 (1997) 133-136 Review
82. Li G., Crang A.J., Rundle J.L., and Blakemore W.F. Oligodendrocyte progenitor cells in the adult rat CNS express myelin oligodendrocyte glycoprotein (MOG). Brain pathol. 12 (2002) 463-471
83. Li W.W., Penderis J., Zhao C., Schumacher M., and Franklin R.J. Females remyelinate more efficiently than males following demyelination in the aged but not young adult CNS. Exp. Neurol. 202 (2006) 250-254
84. Li W.W., Setzu A., Zhao C., and Franklin R.J.M. Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination. J. Neuroimmunol. 158 (2005) 58-66
85. Loughlin A.J., Copelman C.A., Hall A., Armer T., Young B.C., Landon D.N., and Cuzner M.L. Myelination and remyelination of aggregate rat brain cell cultures enriched with macrophages. J. Neurosci. Res. 47 (1997) 384-392
86. Lovas G., Szilagyi N., Majtenyi K., Palkovits M., and Komoly S. Axonal changes if chronically demyelinated cervical spinal cord plaques. Brain 123 (2000) 308-317
87. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., and Lassmann H. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 122 (1999) 2279-2295
88. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., and Lassmann H. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann. Neurol. 47 (2000) 707-717
89. Ludwin S.K. Chronic demyelination inhibits remyelination in the central nervous system. Lab. Invest. 43 (1980) 382-387
90. Luzi P., Zaka M., Rao H.Z., Curtis M., Rafi M.A., and Wenger D.A. Generation of transgenic mice expressing insulin-like growth factor-1 under the control of the myelin basic protein promoter: Increased myelination and potential for studies on the effects of increased IGF-1 on experimentally and genetically induced demyelination. Neurochem. Res. 29 (2004) 881-889
91. Marburg O. Die sogenannte 'akute multiple Sklerose' (Encephalomyelitis periaxialis scleroticans). J. Neurol. Psychiatry 27 (1906) 213-312
92. Marchionni M.A., Cannella B., Hoban C., Gao Y.L., Garcia-Arenas R., Lawson D., Happel E., Noel F., Tofilon P., Gwynne D., and Raine C.S. Neuregulin in neuron/glial interactions in the central nervous system. GGF2 diminishes autoimmune demyelination, promotes oligodendrocyte progenitor expansion, and enhances remyelination. Adv. Exp. Med. Biol. 468 (1999) 283-295
93. Mason J.L., Suzuki K., Chaplin D.D., and Matsushima G.K. Interleukin-1beta promotes repair of the CNS. J. Neurosci. 21 (2001) 7046-7052
94. McKinnon R.D., Piras G., Ida J.A., and Dubois-Dalcq M. A role for TGF-beta in oligodendrocyte differentiation. J. Cell Biol. 121 (1993) 1397-1407
95. Merkler D., Boretius S., Stadelmann C., Ernsting T., Michaelis T., Frahm J., and Bruck W. Multicontrast MRI of remyelination in the central nervous system. NMR Biomed. 18 (2005) 395-403
96. Messersmith D.J., Murtie J.C., Le T.Q., Frost E.E., and Armstrong R.C. Fibroblast growth factor 2 (FGF2) and FGF receptor expression in an experimental demyelinating disease with extensive remyelination. J. Neurosci. Res. 62 (2000) 241-256
97. Mi S., Miller R.H., Lee X., Scott M.L., Shulag-Morskaya S., Shao Z., Chang J., Thill G., Levesque M., Zhang M., Hession C., Sah D., et al. LINGO-1 negatively regulates myelination by oligodendrocytes. Nat. Neurosci. 8 (2005) 745-751
98. Miller R.H. Contact with central nervous system myelin inhibits oligodendrocyte progenitor maturation. Dev. Biol. 216 (1999) 359-368
99. Murtie J.C., Zhou Y.X., Le T.Q., Vana A.C., and Armstrong R.C. PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination. Neurobiol. Dis. 19 (2005) 171-182
100. Nathan C.F. Secretory products of macrophages. J. Clin. Invest. 79 (1987) 319-326 Review
101. Nave K.A. Myelin specific genes and their mutations in the mouse. In: Jessen K.R., and Richardson W.D. (Eds). "Glial Cell Development" (2001), Oxford University Press, Oxford, UK 177-208
102. Niehaus A., Shi J., Grzenkowski M., Diers-Fenger M., Archelos J., Hartung H.P., Toyka K., Bruck W., and Trotter J. Patients with active relapsing-remitting multiple sclerosis synthesize antibodies recognizing oligodendrocyte progenitor cell surface protein: Implications for remyelination. Ann. Neurol. 48 (2000) 362-371
103. Nistor G.I., Totoiu M.O., Haque N., Carpenter M.K., and Keirstead H.S. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia 49 (2005) 385-396
104. Nunes M.C., Roy N.S., Keyoung H.M., Goodman R.R., McKhann G., Jiang L., Kang J., Nedergaard M., and Goldman S.A. Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat. Med. 9 (2003) 439-447
105. O'Leary M.T., and Blakemore W.F. Oligodendrocyte precursors survive poorly and do not migrate following transplantation into the normal adult central nervous system. J. Neurosci. Res. 48 (1997) 159-167
106. O'Leary M.T., Hinks G.L., Charlton H.M., and Franklin R.J. Increasing local levels of IGF-I mRNA expression using adenoviral vectors does not alter oligodendrocyte remyelination in the CNS of aged rats. Mol. Cell. Neurosci. 19 (2002) 32-42
107. Oleszak E.L., Chang J.R., Friedman H., Katset C.D., and Platsoucas C.D. Theiler's virus infection: A model for multiple sclerosis. Clin. Microbiol. Rev. 17 (2004) 174-207 Review
108. Papadopoulos D., Pham-Dinh D., and Reynolds R. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat. Exp. Neurol. 197 (2006) 373-385
109. Penderis J., Shields S.A., and Franklin R.J.M. Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system. Brain 126 (2003) 1382-1391
110. Penderis J., Woodruff R.H., Lakatos A., Li W.W., Dunning M.D., Zhao C., Marchionni M., and Franklin R.J. Increasing local levels of neuregulin (glial growth factor-2) by direct infusion into areas of demyelination does not alter remyelination in the rat CNS. Eur. J. Neurosci. 18 (2003) 2253-2264
111. Perier O., and Gregoire A. Electron microscopic features of multiple sclerosis lesions. Brain 88 (1965) 937-952
112. Pluchino S., and Martino G. The therapeutic use of stem cells for myelin repair in autoimmune demyelinating disorders. J. Neurol. Sci. 233 (2005) 117-119 Review
113. Pluchino S., Zanotti L., Deleidi M., and Martino G. Neural stem cells and their use as therapeutic tool in neurological disorders. Brain Res. Brain Res. Rev. 48 (2005) 211-219
114. Polito A., and Reynolds R. NG2-expressing cells as oligodendrocyte progenitors in the normal and demyelinated adult central nervous system. J. Anat. 207 (2005) 707-716 Review
115. Prineas J.W., and Connell F. Remyelination in multiple sclerosis. Ann. Neurol. 5 (1979) 22-31
116. Prineas J.W., Kwon E.E., Cho E.S., and Sharer L.R. Continual breakdown and regeneration of myelin in progressive multiple sclerosis plaques. Ann. N. Y. Acad. Sci. 436 (1984) 11-32
117. Prineas J.W., Barnard R.O., Revesz T., Kwon E.E., Sharer L., and Cho E.S. Multiple sclerosis. Pathology of recurrent lesions. Brain 116 (1993) 681-693
118. Raine C.S., and Wu E. Multiple sclerosis: Remyelination in acute lesions. J. Neuropathol. Exp. Neurol. 52 (1993) 199-204
119. Redwine J.M., and Armstrong R.C. In vivo proliferation of oligodendrocyte progenitors expressing PDGFalphaR during early remyelination. J. Neurobiol. 37 (1998) 413-428
120. Rodriguez M. A function of myelin is to protect axons from subsequent injury: Implications for deficits in multiple sclerosis. Brain 126 (2003) 751-752
121. Rosen C.L., Bunge R.P., Ard M.D., and Wood P.M. Type 1 astrocytes inhibit myelination by adult rat oligodendrocytes in vitro. J. Neurosci. 9 (1989) 3371-3379
122. Sasaki M., Black J.A., Lankford K.L., Tokuno H.A., Waxman S.G., and Kocsis J.D. Molecular reconstruction of nodes of Ranvier after remyelination by transplanted olfactory ensheathing cells in the demyelinated spinal cord. J. Neurosci. 26 (2006) 1803-1812
123. Schlesinger H. Zur Frage der akuten multiplen Sklerose und der encephalomyelitis disseminata im Kindesalter. Arb. Neurol. Inst. (Wien.) 17 (1909) 410-432
124. Scolding N., Franklin R., Stevens S., Heldin C.H., Compston A., and Newcombe J. Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. Brain 121 (1998) 2221-2228
125. Setzu A., Lathia J.D., Zhao C., Wells K., Rao M.S., Ffrench-Constant C., and Franklin R.J.M. Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells. Glia 54 (2006) 297-303
126. Sherman D.L., and Brophy P.J. Mechanisms of axon ensheathment and myelin growth. Nat. Rev. Neurosci. 6 (2005) 683-690
127. Shi J., Marinovich A., and Barres B.A. Purification and characterization of adult oligodendrocyte precursor cells from the rat optic nerve. J. Neurosci. 18 (1998) 4627-4636
128. Sim F.J., Zhao C., Penderis J., and Franklin R.J.M. The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. J. Neurosci. 22 (2002) 2451-2459
129. Smith E.J., Blakemore W.F., and McDonald W.I. Central remyelination restores secure conduction. Nature 280 (1979) 395-396
130. Smith K.J., Blakemore W.F., and McDonald W.I. The restoration of conduction by central remyelination. Brain 104 (1981) 383-404
131. Stidworthy M.F., Genoud S., Suter U., Mantei N., and Franklin R.J.M. Quantifying the early stages of remyelination following cuprizone-induced demyelination. Brain Pathol. 13 (2003) 329-339
132. Storch M.K., Stefferl A., Brehm U., Weissert R., Wallstrom E., Kerschensteiner M., Olsson T., Linington C., and Lassmann H. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol. 8 (1998) 681-694
133. Tepavcevic V., and Blakemore W.F. Glial grafting for demyelinating disease. Philos. Trans. R. Soc. Lond. B Biol. Sci. 360 (2005) 1775-1795
134. Tourbah A., Linnington C., Bachelin C., Avellana-Adalid V., Wekerle H., and Baron-Van Evercooren A. Inflammation promotes survival and migration of the CG4 oligodendrocyte progenitors transplanted in the spinal cord of both inflammatory and demyelinated EAE rats. J. Neurosci. Res. 50 (1997) 853-861
135. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mork S., and Bo L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338 (1998) 278-285
136. Trebst C., and Stangel M. Promotion of remyelination by immunoglobulins: Implications for the treatment of multiple sclerosis. Curr. Pharm. Des. 12 (2006) 241-249
137. Triarhou L.C., and Herndon R.M. The effect of dexamethasone on L-alpha-lysophosphatidyl choline (lysolecithin)-induced demyelination of the rat spinal cord. Arch. Neurol. 43 (1986) 121-125
138. Viehover A., Miller R.H., Park S.K., Fischbach G., and Vartanian T. Neuregulin: An oligodendrocyte growth factor absent in active multiple sclerosis lesions. Dev. Neurosci. 23 (2001) 377-386
139. Warrington A.E., Asakura K., Bieber A.J., Ciric B., Van Keulen V., Kaveri S.V., Kyle R.A., Pease L.R., and Rodriguez M. Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc. Natl. Acad. Sci. USA 97 (2000) 6820-6825
140. Waxman S.G. Ions, energy and axonal injury: Towards a molecular neurology of multiple sclerosis. Trends Mol. Med. 12 (2006) 192-195
141. Wilkins A., Chandran S., and Compston A. A role for oligodendrocyte-derived IGF-1 in trophic support of cortical neurons. Glia 36 (2001) 48-57
142. Wolswijk G. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J. Neurosci. 18 (1998) 601-609
143. Wolswijk G. Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain 125 (2002) 338-349
144. Woodruff R.H., and Franklin R.J.M. Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: A comparative study. Glia 25 (1999) 216-228
145. Woodruff R.H., Fruttiger M., Richardson W.D., and Franklin R.J.M. Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination. Mol. Cell. Neurosci. 25 (2004) 252-262
146. Ye P., Carson J., and D'Ercole A.J. In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: Studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice. J. Neurosci. 15 (1995) 7344-7356
147. Zhao C., Fancy S.P., Kotter M.R., Li W.W., and Franklin R.J. Mechanisms of CNS remyelination-the key to therapeutic advances. J. Neurol. Sci. 233 (2005) 87-91